We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 8 februari 2018

British Journal of Cancer - Table of Contents alert Volume 118 Issue 3

If you are unable to see the message below, click here to view.
British Journal of Cancer

Advertisement
nature.com webcasts 

Springer Nature presents a custom webcast on: Transforming Translational Research: CANscript™ - A Better Predictive Model For Oncology

Date: Tuesday, February 20, 2018 

Register for the webcast and live Q&A session 

Sponsored by: Mitra Biotech 
TABLE OF CONTENTS

Volume 118, Issue 3 (309-458)
Published online 7 February 2018
 

In this issue
Editorial
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Letters to the Editor

Also new today
Advance online publication
Digital Edition
 
Advertisement
nature.com webcasts 

Springer Nature presents a custom webcast on: Multiple Assays of the Anti-Apoptotic BCL-2 Family

Date: Wednesday, February 28, 2018 

Register for the webcast and live Q&A session
 
Sponsored by: 
Millipore Sigma
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

Back from the dead: TIL apoptosis in cancer immune evasion

Brendan L Horton and Thomas F Gajewski

Br J Cancer 2018 118: 309-311; advance online publication, January 23, 2018; 10.1038/bjc.2017.483

Full Text

Review

Top

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed

Jessica S Brown, Raghav Sundar and Juanita Lopez

Br J Cancer 2018 118: 312-324; advance online publication, November 9, 2017; 10.1038/bjc.2017.376

Abstract | Full Text

Clinical Studies

Top

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

Maëva Salimon, Caroline Prieux-Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak-Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan and Yann Touchefeu

Br J Cancer 2018 118: 325-330; advance online publication, November 23, 2017; 10.1038/bjc.2017.413

Abstract | Full Text

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

Yusuke Shimodaira, Rebecca S Slack, Kazuto Harada, Hsiang-Chun Chen, Tara Sagebiel, Manoop S Bhutani, Jeffrey H Lee, Brian Weston, Elena Elimova, Quan Lin, Fatemeh G Amlashi, Dilsa Mizrak Kaya, Mariela A Blum, Jack A Roth, Stephen G Swisher, Heath D Skinner, Wayne L Hofstetter, Jane E Rogers, Jaennette Mares, Irene Thomas, Dipen M Maru, Ritsuko Komaki, Garrett Walsh and Jaffer A Ajani

Br J Cancer 2018 118: 331-337; advance online publication, December 12, 2017; 10.1038/bjc.2017.423

Abstract | Full Text

S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study

X Wang, D B Zhao, L Yang, Y Chi, Y Tang, N Li, S L Wang, Y W Song, Y P Liu, W Y Liu, H Ren, T Zhang, J Y Wang, X S Chen, H Fang, W H Wang, Y X Li and J Jin

Br J Cancer 2018 118: 338-343; advance online publication, December 12, 2017; 10.1038/bjc.2017.424

Abstract | Full Text

Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2

Rastislav Bahleda, Andrea Varga, Yann Bergé, Jean-Charles Soria, David Schnell, Inga Tschoepe, Martina Uttenreuther-Fischer and Jean-Pierre Delord

Br J Cancer 2018 118: 344-352; advance online publication, January 16, 2018; 10.1038/bjc.2017.436

Abstract | Full Text

Translational Therapeutics

Top

Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation

Hao Feng, Jing-kun Zhao, Tobias S Schiergens, Pu-xiongzhi Wang, Bao-chi Ou, Rami Al-Sayegh, Ming-lun Li, Ai-guo Lu, Shuai Yin and Wolfgang E Thasler

Br J Cancer 2018 118: 353-365; advance online publication, January 2, 2018; 10.1038/bjc.2017.415

Abstract | Full Text

MTOR inhibitor-based combination therapies for pancreatic cancer

Zonera Hassan, Christian Schneeweis, Matthias Wirth, Christian Veltkamp, Zahra Dantes, Benedikt Feuerecker, Güralp O Ceyhan, Shirley K Knauer, Wilko Weichert, Roland M Schmid, Roland Stauber, Alexander Arlt, Oliver H Krämer, Roland Rad, Maximilian Reichert, Dieter Saur and Günter Schneider

Br J Cancer 2018 118: 366-377; advance online publication, January 2, 2018; 10.1038/bjc.2017.421

Abstract | Full Text

HER2 expression patterns in paired primary and metastatic endometrial cancer lesions

Mari Kyllesø Halle, Ingvild Løberg Tangen, Hege Fredriksen Berg, Erling Andre Hoivik, Karen K Mauland, Kanthida Kusonmano, Anna Berg, Antoni Hurtado, Karl Henning Kalland, Anne M Øyan, Ingunn Stefansson, Olav K Vintermyr, Henrica M Werner, Ingfrid S Haldorsen, Jone Trovik, Helga B Salvesen and Camilla Krakstad

Br J Cancer 2018 118: 378-387; advance online publication, November 23, 2017; 10.1038/bjc.2017.422

Abstract | Full Text

Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivo

Liang Zhou, Yu Zhang, Deepak Sampath, Joel Leverson, Yun Dai, Maciej Kmieciak, Matthew Nguyen, Robert Z Orlowski and Steven Grant

Br J Cancer 2018 118: 388-397; advance online publication, December 14, 2017; 10.1038/bjc.2017.432

Abstract | Full Text

Molecular Diagnostics

Top

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients

D Zugna, R Senetta, S Osella-Abate, M T Fierro, A Pisacane, A Zaccagna, A Sapino, V Bataille, A Maurichi, F Picciotto, P Cassoni, P Quaglino and S Ribero

Br J Cancer 2018 118: 398-404; advance online publication, November 9, 2017; 10.1038/bjc.2017.397

Abstract | Full Text

Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia

Li Tan, Hongfa Xu, Guoshu Chen, Xiaoping Wei, Baodan Yu, Jingmei Ye, Lihua Xu and Huo Tan

Br J Cancer 2018 118: 405-415; advance online publication, January 2, 2018; 10.1038/bjc.2017.403

Abstract | Full Text

The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells

Peng Li, Jinbo Chen, Eiji Kashiwagi, Taichi Mizushima, Bin Han, Satoshi Inoue, Hiroki Ide, Koji Izumi and Hiroshi Miyamoto

Br J Cancer 2018 118: 416-420; advance online publication, November 14, 2017; 10.1038/bjc.2017.404

Abstract | Full Text

Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis

Valtteri Häyry, Åsa Kågedal, Eric Hjalmarsson, Pedro Farrajota Neves da Silva, Cecilia Drakskog, Gregori Margolin, Susanna Kumlien Georén, Eva Munck-Wikland, Ola Winqvist and Lars Olaf Cardell

Br J Cancer 2018 118: 421-427; advance online publication, November 23, 2017; 10.1038/bjc.2017.408

Abstract | Full Text

Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation

Mikko T Nieminen, Dyah Listyarifah, Jaana Hagström, Caj Haglund, Daniel Grenier, Dan Nordström, Veli-Jukka Uitto, Marcela Hernandez, Tülay Yucel-Lindberg, Taina Tervahartiala, Mari Ainola and Timo Sorsa

Br J Cancer 2018 118: 428-434; advance online publication, November 16, 2017; 10.1038/bjc.2017.409

Abstract | Full Text

Genetics & Genomics

Top

A core matrisome gene signature predicts cancer outcome

Arseniy E Yuzhalin, Tomas Urbonas, Michael A Silva, Ruth J Muschel and Alex N Gordon-Weeks

Br J Cancer 2018 118: 435-440; advance online publication, January 23, 2018; 10.1038/bjc.2017.458

Abstract | Full Text

Epidemiology

Top

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)

Benjamin Daniels, Belinda E Kiely, Nehmat Houssami, Sarah J Lord, Timothy Dobbins, Christine Y Lu, Robyn L Ward and Sallie-Anne Pearson

Br J Cancer 2018 118: 441-447; advance online publication, November 14, 2017; 10.1038/bjc.2017.405

Abstract | Full Text

Alcohol and oestrogen metabolites in postmenopausal women in the Women’s Health Initiative Observational Study

Mary C Playdon, Sally B Coburn, Steven C Moore, Louise A Brinton, Nicolas Wentzensen, Garnet Anderson, Robert Wallace, Roni T Falk, Ruth Pfeiffer, Xia Xu and Britton Trabert

Br J Cancer 2018 118: 448-457; advance online publication, December 12, 2017; 10.1038/bjc.2017.419

Abstract | Full Text

Letters to the Editor

Top

Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’

Isabel Bravo

Br J Cancer 2018 118: e1; advance online publication, November 16, 2017; 10.1038/bjc.2017.342

Full Text

Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’

Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, Filippo Alongi and Michela Buglione

Br J Cancer 2018 118: e2; advance online publication, November 16, 2017; 10.1038/bjc.2017.406

Full Text

Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’

Sandra Tapial, Daniel Rueda, María Arriba, Juan Luis García, Lorena Brandáriz, Jessica Pérez, Yolanda Rodríguez, Damián García-Olmo, Rogelio González-Sarmiento, Miguel Urioste and José Perea

Br J Cancer 2018 118: e3; advance online publication, January 2, 2018; 10.1038/bjc.2017.343

Full Text

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”

Jeong Mo Bae, Jung Ho Kim, Yoonjin Kwak, Dae-Won Lee, Yongjun Cha, Xianyu Wen, Tae Hun Lee, Nam-Yun Cho, Seung-Yong Jeong, Kyu Joo Park, Sae Won Han, Hye Seung Lee, Tae-You Kim and Gyeong Hoon Kang

Br J Cancer 2018 118: e4; advance online publication, January 2, 2018; 10.1038/bjc.2017.426

Full Text

Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer’

Paolo Bossi, Roberta Granata, Ester Orlandi and Lisa Licitra

Br J Cancer 2018 118: e5; advance online publication, January 23, 2018; 10.1038/bjc.2017.416

Full Text

Reply to ‘Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer”

Steffen Wagner, Claus Wittekindt, Shachi Jenny Sharma, Nora Wuerdemann, Theresa Jüttner, Miriam Reuschenbach, Elena-Sophie Prigge, Magnus von Knebel Doeberitz, Stefan Gattenlöhner, Ernst Burkhardt, Jörn Pons-Kühnemann and Jens Peter Klussmann

Br J Cancer 2018 118: e6; advance online publication, January 23, 2018; 10.1038/bjc.2017.464

Full Text

Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis’

Zu-Bing Mei, Chun-Sheng Luo, Qing-Ming Wang and Wei Yang

Br J Cancer 2018 118: e7; advance online publication, January 4, 2018; 10.1038/bjc.2017.444

Full Text

Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis”

Alex Gordon-Weeks

Br J Cancer 2018 118: e8; advance online publication, January 4, 2018; 10.1038/bjc.2017.445

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature